<i>gem</i>-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension
作者:Marco Blangetti、Barbara Rolando、Elisabetta Marini、Konstantin Chegaev、Stefano Guglielmo、Loretta Lazzarato、Laura Lucarini、Emanuela Masini、Roberta Fruttero
DOI:10.1021/acsmedchemlett.7b00264
日期:2017.10.12
Primary open angle glaucoma is the second most common cause of blindness worldwide. Nitric oxide has recently received particular attention as a potential antiglaucoma agent. In this work, gem-dinitroalkyl benzenes are evaluated for their capability to act as a new class of IOP lowering agents. These derivatives have been endowed with a variety of NO-release capacities and found to relax contracted
原发性开角型青光眼是全世界第二大最常见的失明原因。一氧化氮作为潜在的抗青光眼剂最近受到了特别的关注。在这项工作中,对宝石-二硝基烷基苯作为新型IOP降低剂的能力进行了评估。这些衍生物具有多种NO释放能力,并发现以浓度依赖性方式使收缩的大鼠主动脉条松弛。已经研究了它们在1%剂量的短暂性眼高压兔模型中降低IOP的活性。降低IOP的最有效产品是化合物9 – 11和13,其活性与给药后120分钟的Molsidomine相似。化合物使用卡波姆诱发的青光眼作为IOP的慢性模型,选择9和13进行评估。它们在开始的24小时内导致IOP显着降低,并且其活性维持5天以上,显示出类似Molsidomine的特征。